InvestorsHub Logo
Followers 46
Posts 3151
Boards Moderated 0
Alias Born 05/22/2010

Re: None

Wednesday, 05/18/2011 12:34:08 AM

Wednesday, May 18, 2011 12:34:08 AM

Post# of 7747
LOOK CAREFULLY ..." in addition to an up-front payment, CytRx could receive total payments of up to $120 million, in addition to royalties on sales of products developed by Orphazyme from its molecular chaperone technology." Do a little DD before making bombastics moronic statements.